Paper · 40437501

Reprogramming FGF1 from the natural growth factor to the engineered heparan sulphate biosensor.

Ciura K and 5 others. Cell Commun Signal, 2025. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Reprogramming FGF1 from the natural growth factor to the engineered heparan sulphate biosensor. Papers, record 40437501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40437501

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Reprogramming FGF1 from the natural growth factor to the engineered heparan sulphate biosensor.; PubMed
Journal: Cell Commun Signal; PubMed
Year: 2025; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/40437501/; PubMed
DOI: https://doi.org/10.1186/s12964-025-02269-x; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC12121223/; PubMed
The journal: https://conductscience.org/library/journal-index/101170464; PubMed
Citations, by iCite: 0; iCite
Revised in PubMed: 2026-01-27; PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Ciura K	Krzysztof
2	Sobota O	Olimpia
3	Chorążewska A	Aleksandra
4	Krowarsch D	Daniel
5	Porębska N	Natalia
6	Opaliński Ł	Łukasz

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Fibroblast Growth Factor 1	Major topic
Biosensing Techniques	Major topic
Heparan Sulfate	Major topic
Heparan Sulfate Proteoglycans	Major topic
Humans
Protein Binding

Source PubMed

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Stated by
2021/43/B/NZ1/00245	Narodowe Centrum Nauki	PubMed
2021/43/B/NZ1/00245	Narodowe Centrum Nauki	PubMed
2021/43/B/NZ1/00245	Narodowe Centrum Nauki	PubMed
2021/43/B/NZ1/00245	Narodowe Centrum Nauki	PubMed
2021/43/B/NZ1/00245	Narodowe Centrum Nauki	PubMed
2021/43/B/NZ1/00245	Narodowe Centrum Nauki	PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	10,490,103	Structural basis for FGF receptor dimerization and activation.	Cell	1999	https://conductscience.org/library/papers/10490103	PubMed
2	32,698,317	Monoclonal Antibodies in Cancer Therapy.	Antibodies (Basel)	2020	https://conductscience.org/library/papers/32698317	PubMed
3	16,636,895	Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype.	Breast Cancer Res Treat	2006	https://conductscience.org/library/papers/16636895	PubMed
4	26,177,309	Decoding the Matrix: Instructive Roles of Proteoglycan Receptors.	Biochemistry	2015	https://conductscience.org/library/papers/26177309	PubMed
5	22,807,344	Serglycin in health and diseases.	Anat Rec (Hoboken)	2012	https://conductscience.org/library/papers/22807344	PubMed
6	12,604,799	Structural specificity of heparin binding in the fibroblast growth factor family of proteins.	Proc Natl Acad Sci U S A	2003	https://conductscience.org/library/papers/12604799	PubMed
7	27,773,526	An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering Activities.	J Pharm Sci	2016	https://conductscience.org/library/papers/27773526	PubMed
8	11,069,186	Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.	Nature	2000	https://conductscience.org/library/papers/11069186	PubMed
9	1,646,484	Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.	Science	1991	https://conductscience.org/library/papers/1646484	PubMed
10	15,886,501	Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.	Oncology	2005	https://conductscience.org/library/papers/15886501	PubMed

1 to 10 of 48

See all 48 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
CYP4V2	285,440	PubTator's text mining	https://conductscience.org/library/genes/285440	NCBI Gene
FGF1	2,246	PubTator's text mining	https://conductscience.org/library/genes/2246	NCBI Gene
SDC2	6,383	PubTator's text mining	https://conductscience.org/library/genes/6383	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40437501

GET https://conductscience.org/api/papers/v1/40437501/references?page=2

API reference For AI assistants